日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Efficacy of telemedicine on glycaemic control in nursing home residents with type 2 diabetes on basal-bolus insulin therapy: A randomised controlled trial

远程医疗对接受基础-餐时胰岛素治疗的2型糖尿病养老院居民血糖控制的疗效：一项随机对照试验

期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.70511
Dicembrini, Ilaria; Poggi, Chiara D; Del Vescovo, Gloria G; Marinelli, Christian; Scoccimarro, Daniele; Vitale, Valentina; Silverii, Giovanni A; Drigani, Luca; Pancani, Francesca; Norgiolini, Roberto; Di Cianni, Graziano; Mannucci, Edoardo
代谢
糖尿病
免疫/内分泌
发表日期：2026
文献求助 收藏

Effectiveness in Real World of Once Weekly Semaglutide in People with Type 2 Diabetes: Glucagon-Like Peptide Receptor Agonist Naïve or Switchers from Other Glucagon-Like Peptide Receptor Agonists: Results from a Retrospective Observational Study in Umbria

每周一次司美格鲁肽治疗2型糖尿病患者的真实世界疗效：既往未使用过胰高血糖素样肽受体激动剂或从其他胰高血糖素样肽受体激动剂转换而来的患者：翁布里亚一项回顾性观察研究的结果

期刊:Diabetes Therapy
影响因子:2.6
doi:10.1007/s13300-022-01218-y
Di Loreto, Chiara; Minarelli, Viviana; Nasini, Giovanni; Norgiolini, Roberto; Del Sindaco, Paola
糖尿病
信号转导
代谢
发表日期：2022
文献求助 收藏

Correction to: Effectiveness in Real World of Once Weekly Semaglutide in People with Type 2 Diabetes: Glucagon-Like Peptide Receptor Agonist Naïve or Switchers from Other Glucagon-Like Peptide Receptor Agonists: Results from a Retrospective Observational Study in Umbria

更正：每周一次司美格鲁肽治疗2型糖尿病患者的真实世界疗效：既往未使用过胰高血糖素样肽受体激动剂或从其他胰高血糖素样肽受体激动剂转换而来的患者：翁布里亚回顾性观察研究的结果

期刊:Diabetes Therapy
影响因子:2.6
doi:10.1007/s13300-022-01263-7
Di Loreto, Chiara; Minarelli, Viviana; Nasini, Giovanni; Norgiolini, Roberto; Del Sindaco, Paola
糖尿病
信号转导
代谢
发表日期：2022
文献求助 收藏